Portfolio company
CytoReason
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
CytoReason develops computational disease models and AI software for pharmaceutical and biotechnology companies to support data-driven drug discovery and development decisions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
Owkin
Owkin develops artificial intelligence software for drug discovery and clinical research, serving pharmaceutical companies and academic research institutions.
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
QuantHealth
This company develops an artificial intelligence platform for clinical trial simulation and drug-patient outcome prediction for the pharmaceutical and biotechnology industries.
Relation Therapeutics
This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
